Novartis’s Latest Trial Setback Sinks Stock WSJCholesterol drug setback casts doubt over multibillion-dollar race CNBCNovartis shares sink on second pipeline setback this week ReutersAnother Heart Drug Fails, Shocking Cardiologists The New York TimesDyne Therapeutics stock faces pressure after rival drug fails trial By Investing.com Investing.com India
More News
India’s $10 billion equity rush puts August on track for record
"Handcuffs Await": US Suspends Tech Giant Cognizant's Green Card Filings Over Alleged Visa Abuse
FCNR(B) windfall for banks explained: Who got highest inflows and what it means for investors
Clean power push: India hits 300 GW non-fossil capacity milestone ahead of 2030 target